New Issue | Current Medicinal Chemistry; Volume 27 Issue 4

cmc

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth/mini reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

 

Articles from the journal: Current Medicinal Chemistry; Volume 27 Issue 4

For details on the articles, please visit this link: http://www.eurekaselect.com/node/602/current-medicinal-chemistry/issue/27/2698/4/9716

China honors our Eminent Scientist Prof. Atta ur Rahman with Science and Technology Cooperation Award

 

bentham-news-post

 

BEIJING, Jan 10 (APP):Renowned Pakistani scientist Prof. Dr. Atta-ur-Rahman has been conferred the highest scientific award of China in a ceremony held at the Great Hall of the People here on Friday.

Chinese President Xi Jinping and senior Chinese government officials attended the ceremony. Pakistan Ambassador to China, Nahgmana Alamgir Hashmi was also present on the occasion, according to an official statement issued here.

The International Scientific and Technological Cooperation Award is the most prestigious national science and technology award of China. It is granted to foreign scientists, engineers or organizations that have made important contributions to China’s bilateral or multilateral scientific and technological cooperation.

The ‘China International Science and Technology Cooperation Award’, for the year 2020 has been awarded to Prof. Dr. Atta-ur-Rahman in recognition of his significant contributions in the field of Chemistry.

This top international award has previously been given to several leading scientists of the world including the Nobel Laureates, Dr. Carlo Rubbia (Nobel Prize in physics, 1984) and Dr. Zhores I. Alferov (Nobel Prize in physics, 2000).

It is pertinent to mention here that China and Malaysia have also established major research Centers in his name in recognition of his international eminence.

Currently, Prof. Atta-ur-Rahman is serving as Chairman of Prime Minister’s Task Force on Science and Technology, Vice Chairman on Prime Minister’s Task Force on Technology-Driven Knowledge-Economy, and Co-Chairman, Task Force on Information Technology.

However, he has also served the nation as a federal minister for science and technology, and chairman higher education commission.

Prof. Atta-ur-Rahman is the most decorated scientist of Pakistan having won four civil awards including Tamgha-i-Imtiaz, Sitara-i-Imtiaz, Hilal-i-Imtiaz and the highest national award Nishan-i-Imtiaz.

He obtained his Ph.D. in organic chemistry from Cambridge University (1968). He has 1250 publications in several fields of organic chemistry including 775 research publications, 45 international patents, 69 chapters in books and 341 books published largely by major U.S. and European presses. Atta ur RehmanHe is the Editor-in-Chief of eight European Chemistry journals and is editor of the world’s leading encyclopedic series of volumes on natural products “Studies in Natural Product Chemistry” 62 volumes of which have been published under his editorship? during the last two decades.

 

As many as 82 students have completed their Ph.D. degrees under his supervision. He has also been awarded various national and international awards in recognition of his outstanding contributions to the field of science and technology. To read the full new of our Eminent Scientist Dr. Atta-ur Rahman Please visit: https://bit.ly/2PW3C7a

Press Release | Hunan University of China has established “PROFESSOR ATTA-UR-REHMAN MEDICINE RESEARCH CENTER”

 

bentham news 2.jpg
HUNAN UNIVERSITY OF CHINA HAS ESTABLISHED “PROFESSOR ATTA-UR-REHMAN MEDICINE RESEARCH CENTER”

Hunan University of Chinese Medicine (HUCM) has established the Academician Professor Atta-ur-Rahman One Belt and One Road TCM Research Center at its main campus at Changsha, the capital city of Hunan province in China.

The inaugural ceremony for the research center was conducted on October 24, 2019, along with Annual Bio-TCM International Conference at HUCM. Dr. Wei Wang, Professor at Hunan University of Chinese Medicine, stated on behalf of the university.

“The University recognizes the contributions of Prof. Dr. Atta-ur-Rahman in the field of traditional medicine. This center is indeed a humble recognition of Prof. Atta-ur-Rahman’s tremendous scientific contributions in the field of traditional medicine, and his leadership of developing scientific collaboration between the two countries.”

Prof. Atta-ur-Rahman has a longstanding association with Bentham Science as the Editor in Chief of Current Medicinal Chemistry, a leading journal in the field of medicinal chemistry.

Dr. Atta-ur-RahmanFRS, is the Editor for Current Medicinal Chemistry. Dr. Rahman won the UNESCO Science Prize and was elected Fellow of the Royal Society (London). He was conferred honorary doctorate degrees by many universities including Cambridge University. He was elected Honorary Life Fellow of King’s College, Cambridge University, and the Austrian government honored him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande”) (2007) .He is Foreign Fellow (“Academician”) of Chinese and Korean Academy of Sciences.

Current Medicinal Chemistry (Impact factor 3.46), is one of the inaugural publications of Bentham Science Publishers. Now in its 26th volume, the journal continues to publish frontier reviews in the field, enabling researchers to stay at the forefront of pharmaceutical design, discovery and synthesis. More information about the journal can be found here. 

 

Read full press release to find out more at:  https://benthamscience.com/press-releases/19112901/

Testimonial | Read what our Authors have to say about publishing in our Journal – By Dr. Manuela Merlin Laikowski

 

Manuela Merlin Laikowski-.jpg

 

Journal Name: Current Medicinal Chemistry

Contributed Article: NAChR α4β2 Subtype and their Relation with Nicotine Addiction, Cognition, Depression and Hyperactivity Disorder

Press Release | Bentham Science journals improve impact factor ratings in 2019

 

The latest edition of Journal Citation Reports® 2019 has been published recently, and according to the report, Bentham Science Publishers (BSP) journals have significantly improved their Impact Factors. Current Neuropharmacology is leading the list again with the highest impact factor (IF: 4.568) among all the journals. In total, 40 BSP journals have received Impact Factor ratings this year. The latest results in the JCR 2019 reflect the high quality of research published by Bentham Science.

Journal Citation Reports (JCR) is an annual publication by Clarivate Analytics. JCR has been integrated with the Web of Science and is accessible from the Web of Science-Core Collections. Its purpose is to offer a systematic means to critically evaluate the world’s leading journals, with quantifiable, statistical information based on citation data.

Bentham Science publishes over 100 print & online scholarly subscription journals and books. Learn more about Bentham Science here: http://www.benthamscience.com

 

Read full press release to find out more at: https://www.eurekalert.org/pub_releases/2019-06/bsp-bsl062019.php

Become an Editorial Board Member (EBM) | Current Medicinal Chemistry

 

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Abstracted and Indexed in:

  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Science Citation Index Expanded
  • Index to Scientific Reviews®
  • Biochemistry and Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Research Alert
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Prous Science Integrity®
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • Reference Update
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal Current Medicinal Chemistry is interested in appointing active Editorial Board Member  on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field of interest, please feel free to recommend suitable colleagues for the said position and, if possible, send us their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at hermain@benthamscience.net and CC faizan@benthamscience.net

 

Wordpress.jpg

 

Become a Reviewer | Current Medicinal Chemistry

 

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth/mini reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Abstracted and Indexed in:

  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Science Citation Index Expanded
  • Index to Scientific Reviews®
  • Biochemistry and Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Research Alert
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Prous Science Integrity®
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • Reference Update
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal Current Medicinal Chemistry is interested in appointing active Reviewers on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming a Reviewer, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field of interest, please feel free to recommend suitable colleagues for the said position and, if possible, send us their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at hermain@benthamscience.net and at CC faizan@benthamscience.net

 

Wordpress - Reviewer.jpg

Press Release | Targeting kinetoplastid and apicomplexan thymidylate biosynthesis as antiprotozoal strategy

 

Kinetoplastid and apicomplexan parasites include protozoans which are responsible for human diseases, and cause a serious impact on human health and the socioeconomic growth of developing countries. Chemotherapy is the main option to control these pathogenic organisms. The organisms’ nuclear metabolism is considered a promising area for the provision of antimicrobial therapeutic targets.

The viability of parasitic protozoa is severely diminished by imparing thymidylate (dTMP) biosynthesis. The absence of enzymatic activities which are specifically involved in the formation of dTMP (e.g. dUTPase, thymidylate synthase, dihydrofolate reductase or thymidine kinase) results in decreased de-oxythymidine triphosphate (dTTP) levels and the so-called thymineless death.

In this process, the ratio of deoxyuridine triphosphate (dUTP) as compared to dTTP in the cellular nucleotide pool has a crucial role. A high dUTP/dTTP ratio leads to uracil misincorporation into DNA, which then leads to the activation of DNA repair pathways, DNA fragmentation and eventually cell death.

For the identification and development of drugs, the essential character of dTMP synthesis has stimulated interest. These agents specifically block the biochemical steps involved in thymine nucleotide formation.

The review covers available literature related to drug discovery of agents targeting thymidylate biosynthesis in kinetoplastid (genera Trypanosoma and Leishmania) and apicomplexan (Plasmodium spp and Toxoplasma gondii) protozoans.The most relevant findings concerning novel inhibitory molecules with anti-parasitic activity against these human pathogens are presented in the review. Read full press release to find out more at: https://www.eurekalert.org/pub_releases/2018-12/bsp-tk122618.php

 

01.jpg

 

This article by Dr. Dolores Gonzalez Pacanowska et al. is published in Current Medicinal Chemistry, 2018. The article is available from the following link: http://www.eurekaselect.com/165707

 

CALL FOR PAPERS | Thematic Issue for Current Medicinal Chemistry

 

Journal: Current Medicinal Chemistry

 

Guest Editor(s)Alexandru Mihai GRUMEZESCU
Tentative Publication Date: June, 2019

 

“REGENERATIVE MEDICINE AND TISSUE ENGINEERING”

Biomimetic scaffold which can mimic the native extracellular matrices have been developed by many research groups in order to improve the cell-scaffold interactions and to reach a new level of biocompatibility. These recent developments in the tissue construction area have lead to the idea that organ fabrication can be possible by using the available production techniques in combination with cells and growth factors to restore the function of an affected organ and even to increase the transplantation rate. Combining all those parameters together with the human body’s potential to heal in a proper environment, many products can be developed in order to diagnose and treat critical diseases from an early stage and to undertake the biggest crisis reported at the moment. The aim of this special issue is to present the latest updates in the field. For more details please visit: https://bit.ly/2LIe8PF

 

Email here to submit your paper: hermain@benthamscience.net

                                                          CC: faizan@benthamscience.net

 

thematic flyer cmc

Become an Editorial Board Member (EBM) | Current Medicinal Chemistry

 

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. The journal also publishes reviews on recent patents. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Abstracted and Indexed in:

  • Science Citation Index®
  • Journal Citation Reports/Science Edition
  • InCites
  • Science Citation Index Expanded
  • Index to Scientific Reviews®
  • Biochemistry and Biophysics Citation Index®
  • Current Contents® – Life Sciences
  • Research Alert
  • BIOSIS
  • BIOSIS Previews
  • BIOSIS Reviews Reports and Meetings
  • Prous Science Integrity®
  • MEDLINE/PubMed/Index Medicus
  • Scopus
  • EMBASE/Excerpta Medica
  • Chemical Abstracts Service/SciFinder
  • ProQuest
  • ChemWeb
  • Google Scholar
  • BIOBASE
  • Reference Update
  • PubsHub
  • Index Copernicus
  • MediaFinder®-Standard Periodical Directory
  • Genamics JournalSeek
  • J-Gate
  • CNKI Scholar
  • Suweco CZ
  • TOC Premier
  • EBSCO
  • British Library
  • Ulrich’s Periodicals Directory
  • JournalTOCs

The Journal Current Medicinal Chemistry is interested in appointing active Editorial Board Member  on the Journal’s Board. If you are working in the mentioned field of the journal and are interested in becoming an Editorial Board Member, please send us your CV and a list of publications. If, however, the scope of the journal is not directly related to your field of interest, please feel free to recommend suitable colleagues for the said position and, if possible, send us their CV along with their list of publications. Mention in the subject line, the field of interest and send your CV at:

 

Wordpress.jpg

%d bloggers like this: